News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Diagnovus Announces Collaboration With Cincinnati Children's Hospital Medical Center To Develop First Genetic Test For Patients With Eosinophilic Esophagitis


4/28/2014 9:43:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NASHVILLE, Tenn.--(BUSINESS WIRE)--Diagnovus, LLC, a molecular diagnostic company focused on underserved, aggressive and lesser-known diseases, has entered into a license agreement with Cincinnati Children’s Hospital Medical Center to commercialize the first genomic assay to help physicians diagnose and treat eosinophilic esophagitis (EoE), a debilitating inflammatory condition.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES